Orbimed Advisors - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 135 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is 3.64 and the average weighting 0.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$54,241,000
-9.0%
5,501,1440.0%0.51%
-2.9%
Q4 2020$59,632,000
+26.3%
5,501,144
+20.0%
0.52%
-12.0%
Q3 2020$47,219,000
-31.3%
4,584,344
+39.3%
0.59%
-38.7%
Q2 2020$68,711,000
+103.8%
3,290,744
-4.6%
0.97%
+70.5%
Q1 2020$33,713,000
-32.6%
3,450,644
-20.5%
0.57%
-20.6%
Q4 2019$50,022,000
+128.7%
4,342,190
+8.2%
0.71%
+72.0%
Q3 2019$21,871,000
-6.2%
4,012,969
+104.7%
0.42%
+15.0%
Q2 2019$23,307,000
+257.8%
1,960,200
+57.7%
0.36%
+257.4%
Q1 2019$6,514,0001,243,2000.10%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders